Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers.

Taubert, Max; Chiesa, Joseph; Lückermann, Mark; Fischer, Carsten; Dalhoff, Axel; Fuhr, Uwe

Taubert, Max; Chiesa, Joseph; Lückermann, Mark; Fischer, Carsten; Dalhoff, Axel; Fuhr, Uwe.

Afiliação

Taubert M; Department I of Pharmacology, Clinical Pharmacology Unit, University Hospital Cologne, Cologne, Germany max.taubert@uk-koeln.de.
Chiesa J; Covance Clinical Research Unit, Leeds, United Kingdom.
Lückermann M; MerLion Pharmaceuticals GmbH, Berlin, Germany.
Fischer C; MerLion Pharmaceuticals GmbH, Berlin, Germany.
Dalhoff A; Institute for Infection Medicine, University Hospital Kiel, Kiel, Germany.
Fuhr U; Department I of Pharmacology, Clinical Pharmacology Unit, University Hospital Cologne, Cologne, Germany.

Antimicrob Agents Chemother ; 61(10)2017 10.

Article em En | MEDLINE | ID: mdl-28784673

Assuntos

Antibacterianos/efeitos adversos; Antibacterianos/farmacocinética; Fluoroquinolonas/efeitos adversos; Fluoroquinolonas/farmacocinética; Administração Intravenosa; Método Duplo-Cego; Feminino; Voluntários Saudáveis; Humanos; Masculino; Placebos/administração & dosagem

Palavras-chave

antimicrobial agents; clinical trials; finafloxacin; pharmacology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluoroquinolonas / Antibacterianos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google